Immunovant, Inc.(IMVT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMVT Immunovant, Inc.

盘前交易 12-23 05:28:49 EST

25.86

+0.20

+0.78%

盘前26.29

+0.43+1.66%

04:43 EST

最高26.27	最低25.25	成交量323.73万
今开25.44	昨收25.66	日振幅3.98%
总市值37.96亿	流通市值16.98亿	总股本1.47亿
成交额8,363万	换手率4.93%	流通股本6,566万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMVT","market":"US","secType":"STK","nameCN":"Immunovant, Inc.","latestPrice":25.86,"timestamp":1734728400000,"preClose":25.66,"halted":0,"volume":3237269,"hourTrading":{"tag":"盘前","latestPrice":26.29,"preClose":25.86,"latestTime":"04:43 EST","volume":101,"amount":2642.289987,"timestamp":1734947012473},"delay":0,"floatShares":65661965,"shares":146784639,"eps":-2.215084,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.2,"latestTime":"12-23 05:28:49 EST","open":25.44,"high":26.27,"low":25.25,"amount":83630267.116634,"amplitude":0.039751,"askPrice":26.74,"askSize":30,"bidPrice":25.25,"bidSize":60,"shortable":3,"etf":0,"ttmEps":-2.215084,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734964200000},"adr":0,"adjPreClose":25.86,"preHourTrading":{"tag":"盘前","latestPrice":26.29,"preClose":25.86,"latestTime":"04:43 EST","volume":101,"amount":2642.289987,"timestamp":1734947012473},"postHourTrading":{"tag":"盘后","latestPrice":25.86,"preClose":25.86,"latestTime":"16:36 EST","volume":514765,"amount":13311822.9,"timestamp":1734730619305},"volumeRatio":3.0907554472097276,"impliedVol":0.3549,"impliedVolPercentile":0.128},"requestUrl":"/m/hq/s/IMVT","defaultTab":"news","newsList":[{"id":"2492380177","title":"富国银行：维持Immunovant评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2492380177","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492380177?lang=zh_cn&edition=full","pubTime":"2024-12-19 23:08","pubTimestamp":1734620887,"startTime":"0","endTime":"0","summary":"富国银行：维持immunovant(IMVT.US)评级，由增持调整至增持评级,目标价由47.00美元调整至45.00美元。Immunovant(IMVT.US)公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。它致力于让自身免疫性疾病患者能够正常生活。该公司的产品包括batoclimab和针对新生儿Fc受体(FcRn)的IMVT-1402。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219231501a1fb6b12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219231501a1fb6b12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVT"],"gpt_icon":0},{"id":"2492338201","title":"Immunovant, Inc.盘中异动 早盘急速下挫5.41%报26.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492338201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492338201?lang=zh_cn&edition=full","pubTime":"2024-12-18 23:50","pubTimestamp":1734537028,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日23时50分，Immunovant, Inc.股票出现波动，股价快速下挫5.41%。截至发稿，该股报26.40美元/股，成交量12.4937万股，换手率0.09%，振幅5.23%。Immunovant, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为2484.32%、490.72%、291.62%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为227.62%、118.27%、66.83%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121823502895ea5668&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121823502895ea5668&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVTW","BK4139","IMVT","IMVTU","BK4585","BK4588"],"gpt_icon":0},{"id":"2484600550","title":"Immunovant, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484600550","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484600550?lang=zh_cn&edition=full","pubTime":"2024-11-19 03:13","pubTimestamp":1731957229,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日03时13分，Immunovant, Inc.股票出现异动，股价快速下跌5.03%。截至发稿，该股报25.29美元/股，成交量85.8387万股，换手率0.58%，振幅6.12%。Immunovant, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Hcw Biologics Inc.、冠科美博、Apollomics Inc C/Wts 01/04/2028 涨幅较大，冠科美博、Hcw Biologics Inc.、Tharimmune, Inc.较为活跃，换手率分别为1375.03%、1248.12%、568.91%，振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为563.48%、221.58%、193.44%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119031350971a7424&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119031350971a7424&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","IMVTW","IMVT","IMVTU","BK4585"],"gpt_icon":0},{"id":"2482422145","title":"Immunovant, Inc.2024财年第三财季实现净利润-1.09亿美元，同比减少85.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482422145","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482422145?lang=zh_cn&edition=full","pubTime":"2024-11-10 00:01","pubTimestamp":1731168075,"startTime":"0","endTime":"0","summary":"11月10日，Immunovant, Inc.公布财报，公告显示公司2024财年第三财季净利润为-1.09亿美元，同比减少85.82%；其中营业收入为0.00美元，每股基本收益为-0.75美元。从资产负债表来看，Immunovant, Inc.总负债66.65百万美元，其中短期债务47000.00美元，资产负债比为0.08，流动比率为0.08。机构评级：截至2024年11月10日，当前有15家机构对Immunovant, Inc.目标价做出预测，其中目标均价为49.07美元，其中最低目标价为36.00美元，最高目标价为60.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000139a2278563&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000139a2278563&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVT","IMVTU","IMVTW"],"gpt_icon":0},{"id":"2473386480","title":"Immunovant, Inc.盘中异动 快速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473386480","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473386480?lang=zh_cn&edition=full","pubTime":"2024-10-08 03:11","pubTimestamp":1728328279,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日03时11分，Immunovant, Inc.股票出现异动，股价快速跳水5.00%。截至发稿，该股报28.99美元/股，成交量33.1054万股，换手率0.23%，振幅5.18%。Immunovant, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Scholar Rock Holding Corporation、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Celularity Inc C/Wts 16/07/2026 涨幅较大，Aditxt, Inc.、Tc Biopharm  Plc、Phio Pharmaceuticals Corp.较为活跃，换手率分别为1669.70%、95.96%、60.66%，振幅较大的相关个股有Scholar Rock Holding Corporation、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Lakeshore Biopharma Co., Ltd，振幅分别为107.82%、39.46%、38.72%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410080311199719eb6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410080311199719eb6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","IMVTU","IMVTW","IMVT","BK4139","BK4585"],"gpt_icon":0},{"id":"2459472207","title":"Immunovant, Inc.2024财年第二财季实现净利润-87.15百万美元，同比减少17.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459472207","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459472207?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:02","pubTimestamp":1723737736,"startTime":"0","endTime":"0","summary":"8月16日，Immunovant, Inc.公布财报，公告显示公司2024财年第二财季净利润为-87.15百万美元，同比减少17.87%；其中营业收入为0.00美元，每股基本收益为-0.60美元。从资产负债表来看，Immunovant, Inc.总负债45.02百万美元，其中短期债务69000.00美元，资产负债比为0.14，流动比率为0.14。机构评级：截至2024年8月16日，当前有14家机构对Immunovant, Inc.目标价做出预测，其中目标均价为48.43美元，其中最低目标价为41.00美元，最高目标价为57.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408160002299f2e441b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408160002299f2e441b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVTU","IMVT","IMVTW"],"gpt_icon":0},{"id":"2457234000","title":"Immunovant Inc   预计每股亏损53美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457234000","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457234000?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:55","pubTimestamp":1722952522,"startTime":"0","endTime":"0","summary":"   * Immunovant公司   在8月8日公布截至2024年6月30日的财报时，预计季度收入将没有变化()    *    * LSEG分析师对Immunovant公司的平均预期是每股亏损53美分。* 华尔街对 Immunovant Inc 的 12 个月目标价中位数为 49.00 美元，高于其上次收盘价 26.71 美元。8月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Immunovant Inc   预计每股亏损53美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMVT"],"gpt_icon":0},{"id":"2457737897","title":"Immunovant, Inc.盘中异动 股价大跌5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457737897","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457737897?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:36","pubTimestamp":1722864960,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时36分，Immunovant, Inc.股票出现波动，股价快速下跌5.63%。截至发稿，该股报26.30美元/股，成交量3.6608万股，换手率0.03%，振幅2.73%。Immunovant, Inc.股票所在的生物技术行业中，整体跌幅为1.75%。其相关个股中，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Zevra Therapeutics, Inc.、Okyo Pharma Ltd Com Npv 涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为1027.94%、44.55%、13.93%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.、Portage Biotech Inc.，振幅分别为18.36%、17.59%、16.29%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052136009f10716a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052136009f10716a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","BK4585","IMVTU","IMVT","IMVTW"],"gpt_icon":0},{"id":"2452436702","title":"Immunovant, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452436702","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452436702?lang=zh_cn&edition=full","pubTime":"2024-07-18 23:55","pubTimestamp":1721318145,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日23时55分，Immunovant, Inc.股票出现波动，股价急速下挫5.00%。截至发稿，该股报28.48美元/股，成交量28.6487万股，换手率0.20%，振幅4.90%。Immunovant, Inc.股票所在的生物技术行业中，整体跌幅为2.09%。其相关个股中，Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Onconetix, Inc.、Silo Pharma, Inc.涨幅较大，Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为2243.87%、2121.96%、1182.82%，振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.，振幅分别为93.33%、91.50%、86.24%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718235545aefa5a6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718235545aefa5a6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMVTU","BK4585","IMVT","IMVTW","BK4588","BK4139"],"gpt_icon":0},{"id":"2450363671","title":"Immunovant, Inc.盘中异动 股价大涨5.11%报31.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450363671","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450363671?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:36","pubTimestamp":1720704991,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时36分，Immunovant, Inc.股票出现波动，股价急速拉升5.11%。截至发稿，该股报31.90美元/股，成交量4.1287万股，换手率0.03%，振幅2.50%。Immunovant, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Kazia Therapeutics Limited、Okyo Pharma Ltd Com Npv 、Virpax Pharmaceuticals, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Kazia Therapeutics Limited、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为265.25%、209.46%、178.13%，振幅较大的相关个股有Kazia Therapeutics Limited、Virpax Pharmaceuticals, Inc.、Lexeo Therapeutics, Inc.，振幅分别为40.41%、22.94%、15.15%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213632af91dd7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213632af91dd7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","IMVTU","IMVT","IMVTW","BK4588"],"gpt_icon":0},{"id":"2450071112","title":"Immunovant, Inc.盘中异动 急速拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450071112","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450071112?lang=zh_cn&edition=full","pubTime":"2024-07-10 02:41","pubTimestamp":1720550516,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日02时41分，Immunovant, Inc.股票出现波动，股价急速上涨5.01%。截至发稿，该股报29.04美元/股，成交量44.6068万股，换手率0.31%，振幅5.55%。Immunovant, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。其相关个股中，Soligenix, Inc.、Cingulate Inc C/Wts 10/12/2026 、180 Life Sciences Corp.涨幅较大，Soligenix, Inc.、180 Life Sciences Corp.、Longeveron Inc.较为活跃，换手率分别为12816.63%、3133.66%、357.27%，振幅较大的相关个股有Soligenix, Inc.、180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为468.99%、196.29%、134.00%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100241569681b353&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100241569681b353&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","IMVTU","IMVTW","IMVT","BK4139","BK4585"],"gpt_icon":0},{"id":"2448914777","title":"Immunovant, Inc.盘中异动 股价大涨6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448914777","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448914777?lang=zh_cn&edition=full","pubTime":"2024-07-01 23:26","pubTimestamp":1719847562,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日23时26分，Immunovant, Inc.股票出现波动，股价大幅拉升6.34%。截至发稿，该股报28.08美元/股，成交量18.278万股，换手率0.13%，振幅4.51%。Immunovant, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Senti Biosciences, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Eyenovia, Inc.涨幅较大，Senti Biosciences, Inc.、Geovax Labs, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为610.52%、171.20%、105.43%，振幅较大的相关个股有Senti Biosciences, Inc.、Cingulate Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为101.49%、65.56%、56.01%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701232602af900ad1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701232602af900ad1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMVT","IMVTU","IMVTW","BK4588","BK4585"],"gpt_icon":0},{"id":"2446313713","title":"Immunovant, Inc.盘中异动 快速下跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446313713","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446313713?lang=zh_cn&edition=full","pubTime":"2024-06-27 00:20","pubTimestamp":1719418842,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日00时20分，Immunovant, Inc.股票出现异动，股价急速下跌5.09%。截至发稿，该股报25.90美元/股，成交量61.4893万股，换手率0.42%，振幅4.67%。Immunovant, Inc.股票所在的生物技术行业中，整体跌幅为1.01%。其相关个股中，Anew Medical, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Diamedica Therapeutics Inc.涨幅较大，Anew Medical, Inc.、Cns Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃，换手率分别为673.35%、151.90%、108.22%，振幅较大的相关个股有Anew Medical, Inc.、Effector Therapeutics Inc C/Wts 31/12/2025 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为112.12%、51.85%、45.14%。Immunovant, Inc.公司简介：Immunovant Inc.是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627002042968171f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627002042968171f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","IMVT","BK4588","BK4139","IMVTU","IMVTW"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immunovant.com","stockEarnings":[{"period":"1week","weight":-0.016},{"period":"1month","weight":-0.0118},{"period":"3month","weight":-0.1153},{"period":"6month","weight":-0.0534},{"period":"1year","weight":-0.3386},{"period":"ytd","weight":-0.3862}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immunovant, Inc.于2018年12月6日在特拉华州注册成立,是一家临床阶段生物制药公司，专注于为自身免疫性疾病患者提供正常生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.094855},{"month":2,"riseRate":0,"avgChangeRate":-0.169332},{"month":3,"riseRate":0.2,"avgChangeRate":-0.041053},{"month":4,"riseRate":0.4,"avgChangeRate":-0.020694},{"month":5,"riseRate":0.4,"avgChangeRate":0.099229},{"month":6,"riseRate":0.2,"avgChangeRate":-0.098266},{"month":7,"riseRate":0.5,"avgChangeRate":0.046357},{"month":8,"riseRate":0.666667,"avgChangeRate":0.108139},{"month":9,"riseRate":0.833333,"avgChangeRate":0.124733},{"month":10,"riseRate":0.666667,"avgChangeRate":0.178851},{"month":11,"riseRate":0.666667,"avgChangeRate":0.072037},{"month":12,"riseRate":0.666667,"avgChangeRate":0.151964}],"exchange":"NASDAQ","name":"Immunovant, Inc.","nameEN":"Immunovant, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immunovant, Inc.(IMVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immunovant, Inc.(IMVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immunovant, Inc.,IMVT,Immunovant, Inc.股票,Immunovant, Inc.股票老虎,Immunovant, Inc.股票老虎国际,Immunovant, Inc.行情,Immunovant, Inc.股票行情,Immunovant, Inc.股价,Immunovant, Inc.股市,Immunovant, Inc.股票价格,Immunovant, Inc.股票交易,Immunovant, Inc.股票购买,Immunovant, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immunovant, Inc.(IMVT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immunovant, Inc.(IMVT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}